Moderna Inc. presented new safety data from an early trial providing the first evidence that its Covid-19 vaccine stimulates the immune system of older people. In a Phase 1 trial, Moderna’s coronavirus vaccine produced “consistently high levels” of neutralizing antibodies – a key component of the body’s protective response – …
Read More »Moderna says Covid-19 vaccine shows signs of working in older adults
Moderna Inc. said Wednesday that his experimental coronavirus vaccine caused immune responses in people 56 years and older that were comparable to those seen in younger adults in a small study, a promising sign for a vulnerable age group. Older adults have a higher risk of hospitalization and death of …
Read More »